Skip to main content

ABI, Institute for Systems Biology Pen Proteomics Collaboration

NEW YORK, Aug. 27 - Applied Biosystems and the Institute for Systems Biology today said they will collaborate to develop new proteomic technologies and applications.

 

The partners said they will use mass spectrometry, chemical tagging, and bioinformatics, including LC MALDI workflows, to devise better ways to analyze proteins in various biological pathways.

 

Meantime, ISB will use ABI's 4700 proteomics analyzer with ToF/ToF optics and the ICAT reagent technology to help it study human immunity.

 

ISB researchers in Seattle and teams from ABI's proteomics research center in Framingham, Mass., will perform the research.

 

Click here for more information.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.